A. Harstrick

10.7k citations
128 papers · 8.2k · 1 hit paper · h-index 36

Impact in

  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
  • Hepatology top 1%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 33
    • Cancer Treatment and Pharmacology 30
    • Cancer therapeutics and mechanisms 24

A. Harstrick

126 papers receiving 7.9k citations

A. Harstrick's Hit Papers

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer 2004 · 3.9k citations
3.9k0+7+14Years since publication10002.0k3.0k

Peers

A. Harstrick
Comparison fields: 5 of 121
  • Oncology 5.6k
  • Hepatology 920
  • Pulmonary and Respiratory Medicine 2.9k
  • Otorhinolaryngology 350
  • Pathology and Forensic Medicine 1.0k
Replace Otilia Dalesio with:
Otilia Dalesio Netherlands
Joseph P. Eder United States
Lee S. Rosen United States
P. Koralewski Poland
Stephen K. Williamson United States
Rodryg Ramlau Poland
Helen X. Chen United States
Axel Hinke Germany
Tudor–Eliade Ciuleanu Romania
Harry Bleiberg Belgium
A. Harstrick relative to Otilia Dalesio Netherlands Otilia Dalesio's profile →
Citations per field
00.5×1.6×
Otilia Dalesio · 1×
Citations per year

Countries citing papers authored by A. Harstrick

Since Specialization
Citations

This map shows the geographic impact of A. Harstrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Harstrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Harstrick more than expected).

Fields of papers citing papers by A. Harstrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Harstrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Harstrick. The network helps show where A. Harstrick may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Harstrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Harstrick Line = papers co-authored together A. Harstrick links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
Hit paper breakdown →
20043874
2 2005372
3 2001272
4 1998241
5 2003221
6 1997162
7 1998143
8 2006129
9 1996121
10 1999110
11 1996105
12 1999104
13
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
199898
14 199389
15
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.
200088
16
Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials.
199278
17 199677
18 199675
19 199174
20 200570

About A. Harstrick

A. Harstrick is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine, having authored 128 papers that have together received 8.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (33 papers), Cancer Treatment and Pharmacology (30 papers), Testicular diseases and treatments (29 papers), Cancer therapeutics and mechanisms (24 papers), Gastric Cancer Management and Outcomes (17 papers), Lung Cancer Treatments and Mutations (16 papers), Chemotherapy-induced organ toxicity mitigation (14 papers) and Multiple Myeloma Research and Treatments (13 papers). The work is most often cited by research in Oncology (5.6k citations), Hepatology (920 citations), Pulmonary and Respiratory Medicine (2.9k citations), Otorhinolaryngology (350 citations) and Pathology and Forensic Medicine (1.0k citations). A. Harstrick has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Yves Humblet, David Khayat, Chris Verslype, Salvatore Siena, M. Mueser, Ian Chau, David Cunningham, Harry Bleiberg, Armando Santoro and Eric Van Cutsem. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, Anti-Cancer Drugs and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact